Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Millions of SEK in funding for malaria research at Umeå University

06.09.2005


The molecular biologist Cathrine Persson at Umeå University has been allotted SEK 2.5 million from the U.S. National Institutes of Health (NIH) for research on a vaccine against malaria.

The project “Immunogenicity of synthetic peptide malaria vaccines” spans five years and is designed to study the protection offered by various synthetic vaccines against malaria. Cathrine Persson is collaborating with Professor Elizabeth Nardin, NYU School of Medicine in New York.

The funding is being provided by the National Institute of Allergy and Infectious Diseases (NIAID), one of the 27 institutes and centers that make up the NIH, a federal body that both pursues and provides support for various types of medical research in the U.S. and abroad. The competition for this funding is extremely stiff, and it is not often that scientists in Sweden are selected for grants. The application submitted by Cathrine and her associate was given high scores in the assessment process. Malaria is a major world health problem, and there is no vaccine at present.



“It’s our hope that we will be able to come up with an effective vaccine. This would be a tremendous breakthrough in efforts to develop protection against malaria,” says Cathrine Persson.

Malaria claims several millions of human lives every year and is caused by a group of single-cell parasites (so-called protzoas) that are transmitted to humans by mosquitoes. People who live in malaria-infested areas develop antibodies against the Circumsporozoite protein (CS), a protein on the surface of the malaria parasite. Owing to the ability of CS to stimulate our immune defense, it is included in several trial vaccines that have been tested on humans. A major problem with all vaccine trials is that there is no good way to measure to what extent an individual has developed protection against malaria after being vaccinated. By constructing hybrid parasites that contain parts of the CS protein, Cathrine Persson’s research aims to show what parts of CS are best at stimulating our immune defense. The hybrid parasites will moreover be used as a tool to analyze the outcome of vaccination trials.

Hans Fällman | alfa
Further information:
http://www.molbiol.umu.se/forskning/CathrinePersson
http://www.umu.se

More articles from Health and Medicine:

nachricht Study suggests possible new target for treating and preventing Alzheimer's
02.12.2016 | Oregon Health & Science University

nachricht The first analysis of Ewing's sarcoma methyloma opens doors to new treatments
01.12.2016 | IDIBELL-Bellvitge Biomedical Research Institute

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

Im Focus: Molecules change shape when wet

Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water

In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...

Im Focus: Fraunhofer ISE Develops Highly Compact, High Frequency DC/DC Converter for Aviation

The efficiency of power electronic systems is not solely dependent on electrical efficiency but also on weight, for example, in mobile systems. When the weight of relevant components and devices in airplanes, for instance, is reduced, fuel savings can be achieved and correspondingly greenhouse gas emissions decreased. New materials and components based on gallium nitride (GaN) can help to reduce weight and increase the efficiency. With these new materials, power electronic switches can be operated at higher switching frequency, resulting in higher power density and lower material costs.

Researchers at the Fraunhofer Institute for Solar Energy Systems ISE together with partners have investigated how these materials can be used to make power...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

UTSA study describes new minimally invasive device to treat cancer and other illnesses

02.12.2016 | Medical Engineering

Plasma-zapping process could yield trans fat-free soybean oil product

02.12.2016 | Agricultural and Forestry Science

What do Netflix, Google and planetary systems have in common?

02.12.2016 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>